Study of the Safety and Immunogenicity of a Novel H5N1 Influenza Vaccine in Healthy Adults Age 18-49
Clinical trial NCT01658800 · COMPLETED
Trial details
- NCT number
- NCT01658800
- Sponsor
- VaxInnate Corporation
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2012-09-01
- Primary completion
- 2013-09-01
- Enrollment
- 275
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.